The Fight against Autism with Canada Drugs

Feb 6
10:28

2012

Remcel Mae P. Canete

Remcel Mae P. Canete

  • Share this article on Facebook
  • Share this article on Twitter
  • Share this article on Linkedin

Many kids with autism also have other developmental or psychiatric states, which includes learning disabilities, speech delays, attention or seizure disorders and anxiety. Higher form of Canada drugs could be of great help in this matter.

mediaimage

Many kids with autism also have other developmental or psychiatric states,The Fight against Autism with Canada Drugs Articles which includes learning disabilities, speech delays, attention or seizure disorders and anxiety.  Higher form of Canada drugs could be of great help in this matter. 

"We don't know what changed the diagnosis. However, we want to deliver the message that it's important to look at the other coexisting conditions, evaluate them before you make a diagnosis, and also recognize these conditions vary by development age," said study author Li-Ching Lee, an associate scientist in the epidemiology and mental health departments at the School of Public Health. 

Overall, children with two or more co-occurring developmental or psychiatric conditions were five times more likely than kids with fewer coexisting conditions to continue to have an autism diagnosis, the researchers said. 

Kids who had a moderate-to-severe learning disability were 11 times more likely to continue to have an autism diagnosis over time, while kids with a developmental delay were nine times more likely to retain an autism diagnosis, the study authors said.  To buy Strattera will surely help improve the condition of patients suffering from autism. 

Dr. Joseph Horrigan, assistant vice president and head of medical research for the advocacy group Autism Speaks, cautioned not to make too much of the findings. The children weren't actually followed over time, nor were they actually examined, a methodology that would be the "gold standard" of research. 

Because the results were based on a telephone survey, Horrigan said, "I'd be a little cautious about over-interpreting whether this means there's likely to be change in an autism diagnosis or a loss of an autism diagnosis for a given individual." 

"Up until the recent past, there's been a tendency to spend most of the time and energy on the autism and the autism diagnosis, and thinking about a treatment package that's keyed directly to the autism," Horrigan said. "What's important here is they are highlighting some of the most common co-occurring disorders, a number of which are readily amenable to treatments."  In this endeavor to solve the mystery of autism, Canadian pharmacy fully supports various organizations and institutions doing related researches and studies.